XML 68 R59.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-Based Compensation - Stock-Based Compensation Expense (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Share-Based Compensation Expense [Line Items]    
Total stock-based compensation expense $ 10.1 $ 9.0
Cost of molecular diagnostic testing    
Share-Based Compensation Expense [Line Items]    
Total stock-based compensation expense 0.3 0.3
Cost of pharmaceutical and clinical services    
Share-Based Compensation Expense [Line Items]    
Total stock-based compensation expense 0.0 0.1
Research and development expense    
Share-Based Compensation Expense [Line Items]    
Total stock-based compensation expense 2.4 1.5
Selling, general, and administrative expense    
Share-Based Compensation Expense [Line Items]    
Total stock-based compensation expense $ 7.4 $ 7.1